Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can "drop in" expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.

Show more
TypeInvestor
HQCambridge, US
Founded1996
Websitempmcapital.com
MPM Capital was founded in 1996 and is headquartered in Cambridge, US
Report incorrect company information

Viewing summary data as a guest

Sign up for free to see all data

Key People/Management at MPM Capital

Patrick Baeuerle

Patrick Baeuerle

Executive Partner
Christiana Bardon

Christiana Bardon

Managing Director
Vinay Bhaskar

Vinay Bhaskar

Principal
Detlev Biniszkiewicz

Detlev Biniszkiewicz

Executive Partner
Lauren Cauley

Lauren Cauley

CFO
Scott Chappel

Scott Chappel

Executive Partner
Show more

MPM Capital Office Locations

MPM Capital has an office in Cambridge
Cambridge, US (HQ)
450 Kendall St
Show all (1)
Report incorrect company information

MPM Capital News and Updates

MPM Capital and Versant Ventures Launch CODA Biotherapeutics to Accelerate Development of Chemogenetic Gene Therapy Platform

SOUTH SAN FRANCISCO, Calif., Sept. 12, 2018 /PRNewswire/ -- CODA Biotherapeutics, Inc., a preclinical-stage biopharmaceutical company developing a chemogenetic gene therapy platform for the treatment of intractable diseases, today debuted with a $19 million Series A financing. Lead...

MPM Capital to raise $400 mln venture fund

MPM Capital has set out to raise a $400 million venture fund, according to a filing with the SEC.

MPM Capital expands medical and scientific advisory board with new addition

MPM Capital has added Dr. Stephen J. Elledge to its medical and scientific advisory board. Elledge is a professor at Harvard Medical School.
Report incorrect company information

MPM Capital Company Life and Culture

Report incorrect company information